Segment Reporting

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Segment Reporting

14. SEGMENT REPORTING

The Company’s operations involve products and services which are managed separately. Accordingly, it operates in two segments: 1) regenerative medicine and 2) contract services.

Certain information concerning the Company’s segments is presented in the following tables (in thousands):

	For the Three Months Ended March 31,
	2020			2019
Net revenues:
Reportable segments:
Regenerative medicine	$	428		$	297
Contract services		505			1,168
Total net revenues	$	933		$	1,465
Net loss:
Reportable segments:
Regenerative medicine	$	(12,703	)	$	(25,209	)
Contract services		(337	)		(364	)
Total net loss	$	(13,040	)	$	(25,573	)